Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN TECHNOLOGIES

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

SUN PHARM

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve RISEDRONATE SODIUM

Comment Full text

PRINSTON INC

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 38
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 39
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

SAPTALIS PHARMS

  • FDA Approval
  • Jan. 09, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

FRESENIUS KABI

  • FDA Approval
  • Jan. 09, 2024, 09:48 UTC
  • 43
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

MYLAN

  • FDA Approval
  • Jan. 09, 2024, 09:48 UTC
  • 39
  • 0 comments

FDA approve IMATINIB MESYLATE

Comment Full text

INNOGENIX

  • FDA Approval
  • Jan. 09, 2024, 09:48 UTC
  • 41
  • 0 comments

FDA approve METRONIDAZOLE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Jan. 09, 2024, 09:48 UTC
  • 39
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text
  • Previous
  • 578
  • 579
  • 580
  • 581
  • 582
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328526)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183624)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin